Recognition and treatment of juvenile-onset spondyloarthritis

Current Opinion in Rheumatology

Volumn 18, Issue 5, 2006, Pages 507-511

  Gensler, Lianne ^a   Davis Jr , John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ankylosing spondylitis; Classification; Diagnosis; Juvenile; Spondyloarthritis; Therapy

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; EARLY DIAGNOSIS; ENTHESITIS; FUNCTIONAL STATUS; HUMAN; IMAGE ANALYSIS; JUVENILE ONSET SPONDYLOARTHRITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; REVIEW; SPINE RADIOGRAPHY; SYMPTOM;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SPONDYLITIS, ANKYLOSING; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746914410     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000240363.09218.61     Document Type: Review

References (31)

1. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361-368.
2. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31:390-392.
3. Prieur AM, Listrat V, Dougados M. Evaluation of the ESSG and the Amor criteria for juvenile spondyloarthropathies (JSA): study of 310 consecutive children referred to one pediatric rheumatology center. Arthritis Rheum 1990; 33:D195.
4. Prieur AM, Listrat V, Dougados M, et al. Criteria for classification of spondyloarthropathies in children. Arch Fr Pediatr 1993; 50:379-385.
5. Burgos-Vargas R, Rudwaleit M, Sieper J. The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis International League of Associations for Rheumatology. J Rheumatol 2002; 29:869-874.
6. Kasapcopour O, Demirli N, Arisoy N, et al. Evaluation of classification criteria for juvenile-onset spondyloarthropathies. Rheumatol Int 2005; 25:414-418.
7. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to Ankylosing Spondylitis. J Rheumatol 1989; 16:192-197.
8. Tse S, Laxer R. Juvenile spondyloarthropathy. Curr Opin Rheumatol 2003; 15:374-379.
9. Burgos-Vargas R, Vazquez-Mellado J. The early clinical recognition of juvenile-onset Ankylosing Spondylitis and its clinical differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38:835-844.
10. Burgos-Vargas R, Vazquez-Mellado J, Cassis N, et al. Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria. J Rheumatol 1996; 23:2140-2147.
11. Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with Ankylosing Spondylitis. Rheumatol Int 2003; 23:61-66.
12. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early Ankylosing Spondylitis: do we need new criteria? Arthritis Rheum 2005; 52:1000-1008.
13. Bollow M, Braun J, Hamm B, et al. Use of contrast-enhanced MR imaging to detect sacroiliitis in children. Skeletal Radiol 1998; 27:606-616.
14. Bollow M, Biedermann T, Braun J, et al. Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA B-27 positive and negative children with juvenile arthritides. J Rheumatol 1998; 25:556-564.
15. Weisman M, Reveille M, van der Heijde D. Ankylosing spondylitis and the spondyloarthropathies. In: Burgos-Vargas R, editor. A companion to rheumatology, 3rd ed. Mosby: St Louis; 2006. pp. 94-106. This is an outstanding book chapter review on juvenile-onset spondyloarthritis.
16. Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. The juvenile-onset spondyloarthritides: rationale for clinical evaluation. Best Pract Res Clin Rheumatol 2002; 16:551-572.
17. Huppertz H, Voight I, Muller-Scholden J, et al. Cardiac manifestations in patients with HLA B-27-associated juvenile arthritis. Pediatr Cardiol 2000; 21:141-147.
18. Camiciottoli G, Trapani S, Ermini M, et al. Pulmonary function in children affected by juvenile spondyloarthropathy. J Rheumatol 1999; 26:1382-1386.
19. Shaw KL, Southwood TR, McDonagh JE. British Society of Pediatric and Adolescent Rheumatology. Growing up and moving on in rheumatology: a multicenter cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 2005; 44:806-812.
20. Zochling J, van der Heijde D, Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65:442-452. This is the most recent consensus statement based on evidence and expert guidelines for the management of ankylosing spondylitis in adult patients. There is no current statement for pediatric patients.
21. Braun J, Davis J, Dougados M, et al. For the ASAS working group. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with Ankylosing Spondylitis. Ann Rheum Dis 2006; 65:316-320.
22. Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor-α blockade in the treatment of juvenile spondyloarthropathy. Arthritis Rheum 2005; 52:2103-2108. This was one of the few studies in the literature assessing the efficacy of anti TNF-α blockade for the treatment of juvenile-onset spondyloarthritis. This was an open-label pilot cohort study.
23. Henrickson M, Reiff A. Prolonged efficacy of Etanercept in refractory enthesitis-related arthritis. J Rheumatol 2004; 31:2055-2061.
24. Rudwaleit M, Listing J, Brandt J, et al. Prediction of a major clinical response (BASDAI 50) to tumor necrosis alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004; 63:665-670.
25. Cabral DA, Oen KG, Petty RE. SEA syndrome revisited: a long-term follow-up of children with a syndrome of seronegative enthesopathy and arthropathy. J Rheumatol 1992; 19:1282-1285.
26. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 1989; 16:192-197.
27. Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study II Outcome. J Rheumatol 1995; 22:308-319.
28. Garcia-Morteo O, Maldonado-Cocco JA, Suarez-Almador ME, Garay E. Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand J Rheumatol 1983; 12:246-248.
29. Selvaag AM, Lien G, Sorskaar D, et al. Early disease course predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study. J Rheumatol 2005; 32:1122-1130.
30. Flato B, Aasland A, Vinje O, Forre O. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998; 25:366-375.
31. Stone M, Warren RW, Bruckel J, et al. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 2005; 53:445-451.